HEATR6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.590000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.314100E-02
Normal-vs-Stage2
4.032200E-04
Normal-vs-Stage3
2.543900E-02
Normal-vs-Stage4
1.145220E-01
Stage1-vs-Stage2
6.945400E-01
Stage1-vs-Stage3
1.114210E-01
Stage1-vs-Stage4
8.796400E-01
Stage2-vs-Stage3
9.476000E-02
Stage2-vs-Stage4
6.132400E-01
Stage3-vs-Stage4
1.165810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.182500E-04
Normal-vs-AfricanAmerican
7.198200E-02
Normal-vs-Asian
2.355700E-02
Caucasian-vs-AfricanAmerican
3.238000E-01
Caucasian-vs-Asian
8.416200E-01
AfricanAmerican-vs-Asian
3.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.121590E-03
Normal-vs-Female
9.162200E-04
Male-vs-Female
4.522800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.507190E-01
Normal-vs-Age(41-60Yrs)
2.130200E-01
Normal-vs-Age(61-80Yrs)
1.023060E-03
Normal-vs-Age(81-100Yrs)
2.783700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.228200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.617200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.780400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.856600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.086300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.477600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.367600E-04
Normal-vs-Daily Drinker
1.319490E-03
Normal-vs-Weekly Drinker
2.099700E-03
Normal-vs-Occasional Drinker
3.787600E-02
Normal-vs-Social Drinker
6.808100E-02
Non Drinker-vs-Daily Drinker
6.799000E-01
Non Drinker-vs-Weekly Drinker
5.417800E-01
Non Drinker-vs-Occasional Drinker
3.661700E-02
Non Drinker-vs-Social Drinker
5.598000E-04
Daily Drinker-vs-Weekly Drinker
8.427000E-01
Daily Drinker-vs-Occasional Drinker
1.230850E-01
Daily Drinker-vs-Social Drinker
5.720200E-03
Weekly Drinker-vs-Occasional Drinker
2.143400E-01
Weekly Drinker-vs-Social Drinker
1.347850E-02
Occasional Drinker-vs-Social Drinker
2.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.069380E-01
Normal-vs-Grade 2
2.286400E-02
Normal-vs-Grade 3
3.335800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.923800E-01
Grade 1-vs-Grade 3
9.804200E-01
Grade 1-vs-Grade 4
1.069380E-01
Grade 2-vs-Grade 3
2.613200E-01
Grade 2-vs-Grade 4
2.286400E-02
Grade 3-vs-Grade 4
3.335800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.259300E-03
Normal-vs-NonDiabetic
5.990000E-04
Diabetic-vs-NonDiabetic
4.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.628790E-01
Normal-vs-NoPancreatitis
7.039700E-04
Pancreatitis-vs-NoPancreatitis
9.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.304300E-03
Normal-vs-N1
2.406400E-04
N0-vs-N1
2.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.762620E-01
Normal-vs-TP53-NonMutant
1.285920E-02
TP53-Mutant-vs-TP53-NonMutant
3.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
